Nxstage Medical Inc (NXTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,720 | 22,095 | 24,455 | 19,958 | 26,642 |
| Receivables | 14,238 | 11,668 | 9,510 | 9,645 | 11,886 |
| Inventories | 28,117 | 27,754 | 28,781 | 30,424 | 30,862 |
| TOTAL | $65,302 | $63,590 | $64,869 | $62,222 | $71,401 |
| Non-Current Assets | |||||
| PPE Net | 32,062 | 35,782 | 36,716 | 39,160 | 42,699 |
| Intangibles | 70,906 | 71,605 | 72,304 | 73,003 | 73,702 |
| Other Non-Current Assets | 28,708 | 24,493 | 25,076 | 25,254 | 24,264 |
| TOTAL | $131,676 | $131,880 | $134,096 | $137,417 | $140,665 |
| Total Assets | $196,978 | $195,470 | $198,965 | $199,639 | $212,066 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 61 | 62 | 59 | 10,531 | 9,110 |
| Accounts payable and accrued liabilities | 19,827 | 17,341 | 14,414 | 16,548 | 17,183 |
| Accrued Expenses | 9,377 | 10,652 | 8,998 | 9,383 | 10,746 |
| TOTAL | $29,265 | $28,055 | $23,471 | $36,462 | $37,039 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,854 | 37,226 | 36,597 | 17,541 | 21,054 |
| Other Non-Current Liabilities | 1,923 | 2,008 | 1,955 | 1,820 | 1,892 |
| TOTAL | $78,267 | $72,000 | $72,244 | $49,665 | $52,580 |
| Total Liabilities | $107,532 | $100,055 | $95,715 | $86,127 | $89,619 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,278 | 46,697 | 46,663 | 46,575 | 46,550 |
| Common Shares | 47 | 47 | 47 | 47 | 47 |
| Retained earnings | -276,714 | -268,037 | -257,990 | -245,475 | -233,247 |
| Other shareholders' equity | 565 | 471 | 428 | 321 | 381 |
| TOTAL | $89,446 | $95,415 | $103,250 | $113,512 | $122,447 |
| Total Liabilities And Equity | $196,978 | $195,470 | $198,965 | $199,639 | $212,066 |